Interstitial lung disease evaluation: Detecting connective tissue disease

Respiration

Volumn 90, Issue 3, 2015, Pages 177-184

  Fischer, Aryeh ^a   Lee, Joyce S ^a   Cottin, Vincent ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Collagen vascular disease; Connective tissue disease; Interstitial lung disease; Interstitial pneumonia; Pulmonary fibrosis

Indexed keywords

AUTOANTIBODY; RHEUMATOID FACTOR;

CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE CLASSIFICATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG LAVAGE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SEROLOGY; SYNOVITIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; X RAY; AGE DISTRIBUTION; AGED; COMORBIDITY; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASES; EVALUATION STUDY; FEMALE; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO;

AGE DISTRIBUTION; AGED; COMORBIDITY; CONNECTIVE TISSUE DISEASES; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84954393130     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000440665     Document Type: Review

References (47)

1. ATS/ERS: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 165 277-304.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al: An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
3. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al: An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
4. Fischer A, du Bois R: Interstitial lung disease in connective tissue disorders. Lancet 2012; 380: 689-698.
5. Castelino FV, Varga J: Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 2010; 12: 213.
6. Doyle TJ, Hunninghake GM, Rosas IO: Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 2012; 185: 1147-1153.
7. Cottin V: Interstitial lung disease. Eur Respir Rev 2013; 22: 26-32.
8. Cottin V: Interstitial lung disease: are we missing formes frustes of connective tissue disease?. Eur Respir J 2006; 28: 893-896.
9. Tzelepis GE, Toya SP, Moutsopoulos HM: Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008; 31: 11-20.
10. Fischer A, Brown KK: Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res (Hoboken) 2015; 67: 4-11.
11. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al: An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015, Epub ahead of print
12. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
13. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
14. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ: Prednisone, azathioprine, and N-Acetylcysteine for pulmonary fibrosis. N Engl J Med 2012; 366: 1968-1977.
15. Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, et al: Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008; 178: 948-955.
16. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE Jr, et al: Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest 2004; 125: 2169-2174.
17. Fischer A, Krishnamoorthy M, Olson AL, Solomon JJ, Fernandez-Perez ER, Huie TJ, et al: Mycophenolate mofetil (MMF) in various interstitial lung diseases (abstract). Am J Respir Crit Care Med 2012; 185: A3638.
18. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al: Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655-2666.
19. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, et al: Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-711.
20. Kim EJ, Collard HR, King TE Jr: Rheumatoid arthritis-Associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009; 136: 1397-1405.
21. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, et al: Usual interstitial pneumonia in rheumatoid arthritis-Associated interstitial lung disease. Eur Respir J 2010; 35: 1322-1328.
22. Hwang JH, Misumi S, Sahin H, Brown KK, Newell JD, Lynch DA: Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J Comput Assist Tomogr 2009; 33: 410-415.
23. Lynch DA: Quantitative CT of fibrotic interstitial lung disease. Chest 2007; 131: 643-644.
24. Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA, et al: Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236: 10-21.
25. Kowal-Bielecka O, Kowal K, Highland KB, Silver RM: Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum 2012; 40: 73-88.
26. Chung JH, Chawla A, Peljto AL, Cool CD, Groshong SD, Talbert JL, et al: CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest 2015; 147: 450-459.
27. Fischer A, Chartrand S: Assessment and management of connective tissue disease-Associated interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2015; 32: 2-21.
28. Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK: Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 2009; 103: 1152-1158.
29. Fischer A, Richeldi L: Cross-disciplinary collaboration in connective tissue disease-related lung disease. Semin Respir Crit Care Med 2014; 35: 159-165.
30. Fischer A, du Bois RM: A Practical Approach to Connective Tissue Disease-Associated Lung Disease, ed 2. New York, Springer, 2012.
31. Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK: Unique characteristics of systemic sclerosis sine scleroderma-Associated interstitial lung disease. Chest 2006; 130: 976-981.
32. Fischer A, Swigris JJ, du Bois RM, Lynch DA, Downey GP, Cosgrove GP, et al: Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009; 103: 1719-1724.
33. Solomon DH, Kavanaugh AJ, Schur PH; American College of Rheumatology Ad Hoc Committee on Immunologic Testing G: Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434-444.
34. Shanmugam VK, Swistowski DR, Saddic N, Wang H, Steen VD: Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clin Rheumatol 2011; 30: 1363-1368.
35. Fischer A, Pfalzgraf FJ, Feghali-Bostwick CA, Wright TM, Curran-Everett D, West SG, et al: Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol 2006; 33: 1600-1605.
36. Lega JC, Cottin V, Fabien N, Thivolet-Bejui F, Cordier JF: Interstitial lung disease associated with anti-PM/Scl or anti-Aminoacyl-tRNA synthetase autoantibodies: a similar condition?. J Rheumatol 2010; 37: 1000-1009.
37. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, et al: The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-Analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 2014; 13: 883-891.
38. Goodwin JS, Searles RP, Tung KS: Immunological responses of healthy elderly population. Clin Exp Immunol 1982; 48: 403-410.
39. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM: High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.
40. Leslie KO, Trahan S, Gruden J: Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007; 28: 369-378.
41. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, et al: Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003; 167: 1410-1415.
42. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS: Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009; 136: 23-30.
43. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, et al: Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39: 661-668.
44. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM: Connective tissue disease-Associated interstitial lung disease: a call for clarification. Chest 2010; 138: 251-256.
45. Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, et al: Idiopathic non-specific interstitial pneumonia: as an autoimmune interstitial pneumonia. Respir Med 2005; 99: 234-240.
46. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, et al: Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 2007; 176: 691-697.
47. Vij R, Noth I, Strek ME: Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011; 140: 1292-1299.